NYSE:BRC • US1046741062
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BRADY CORPORATION - CL A (BRC).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-01-02 | B of A Securities | Upgrade | Underperform -> Buy |
| 2022-02-18 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2022-01-10 | Wells Fargo | Maintains | Overweight |
| 2021-06-08 | Wells Fargo | Upgrade | Underweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.332B 2.29% | 1.341B 0.71% | 1.514B 12.84% | 1.618B 6.90% | 1.68B 3.83% | N/A | |
| EBITDA YoY % growth | 257.6M 13.38% | 273.287M 6.09% | 291.182M 6.55% | 337.34M 15.85% | 361.58M 7.19% | 385.82M 6.70% | |
| EBIT YoY % growth | 225.2M 16.68% | 243.414M 8.09% | 250.543M 2.93% | 284.01M 13.36% | 311.38M 9.64% | 335.83M 7.85% | |
| Operating Margin | 16.91% | 18.15% | 16.55% | 17.55% | 18.53% | N/A | |
| EPS YoY % growth | 3.64 18.69% | 4.21 15.66% | 4.60 9.26% | 5.10 10.77% | 5.55 8.92% | N/A |
All data in USD
| Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.38 13.00% | 1.40 11.02% | 1.34 10.60% | 1.23 12.58% | 1.46 6.23% | 1.52 8.30% |
| Revenue Q2Q % growth | 409.63M 7.07% | 419.78M 5.66% | 421.74M 4.06% | 394.49M 2.70% | 425.39M 3.85% | 436.67M 4.02% |
| EBITDA Q2Q % growth | 89.082M -11.16% | 89.486M -16.31% | 87.163M 10.36% | 83.123M 7.72% | 96.96M 8.84% | 98.273M 9.82% |
| EBIT Q2Q % growth | 75.548M 7.94% | 75.952M 14.57% | 74.841M 10.11% | 70.801M 10.74% | 84.638M 12.03% | 85.648M 12.77% |
All data in USD
6 analysts have analysed BRC and the average price target is 103.02 USD. This implies a price increase of 12.43% is expected in the next year compared to the current price of 91.63.
BRADY CORPORATION - CL A (BRC) will report earnings on 2026-05-14.
The consensus EPS estimate for the next earnings of BRADY CORPORATION - CL A (BRC) is 1.38 USD and the consensus revenue estimate is 409.63M USD.